EDGAR Filing Documents for 0001193125-17-212575

Form 8-K - Current report:

SEC Accession No. 0001193125-17-212575

Filing Date

2017-06-26

Accepted

2017-06-26 10:14:03

Documents

Period of Report

2017-06-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d408101d8k.htm	8-K	23094
2	EX-1.1	d408101dex11.htm	EX-1.1	173364
3	EX-5.1	d408101dex51.htm	EX-5.1	7694
4	EX-99.1	d408101dex991.htm	EX-99.1	7837
5	EX-99.2	d408101dex992.htm	EX-99.2	7857
6	EX-99.3	d408101dex993.htm	EX-99.3	7687
7	GRAPHIC	g408101clovis.jpg	GRAPHIC	5232
	Complete submission text file	0001193125-17-212575.txt		236050

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301

Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000

Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)